This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 35701457
Submitted by lobbyist on: January 2, 2018 02:34:04 PM
Accepted by Registrar on: January 2, 2018 04:07:08 PM
Lobbyist Information
| Marsh, Kyle |
| 777 Hornby St Suite 1600 | |
|
Vancouver, BC, V6Z 2T3
|
604-602-6550 |
| Canada |
BC Public Office Background
| Public Office Title | Description of Role | From | To |
|---|---|---|---|
| Political Staff | Ministerial Assistant to British Columbia's Minister of Health | 10/06/2014 | 05/29/2015 |
| Political Staff | Ministerial Assistant to British Columbia's Minister of Jobs, Tourism and Skills Training | 07/28/2014 | 10/03/2014 |
| Political Staff | Ministerial Assistant to British Columbia's Minister of Energy and Mines | 04/28/2014 | 07/25/2014 |
| Political Staff | Chief of Staff to British Columbia's Minister of Energy and Mines | 06/13/2013 | 04/25/2014 |
| Political Staff | Executive Assistant to British Columbia's Minister of Community, Sport and Cultural Development | 03/05/2012 | 04/16/2013 |
Lobbyist Firm Information
| FleishmanHillard HighRoad |
| 777 Hornby St Suite 1600 | |
|
Vancouver, BC, V6Z 2T3
|
604-602-6550 |
| Canada |
Client Information
| Janssen Inc |
| Janssen Inc., a pharmaceutical company of Johnson & Johnson, has been an innovator in the Canadian healthcare industry for over 50 years. |
| 19 Green Belt Dr. | |
|
Toronto, ON, M3C 1L9
|
416-449-9444 |
| Canada |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
| December 20, 2017 | |
| November 8, 2018 |
Other Individuals Engaged to Lobby
| Reder, Mark |
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
engage government in discussions on the policy surrounding the use and reimbursement of biologic medications
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health | January 2, 2018 |